Drug Shortage Report for PRISTIQ
Report ID | 102502 |
Drug Identification Number | 02321106 |
Brand name | PRISTIQ |
Common or Proper name | Pristiq |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DESVENLAFAXINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 30's |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-01-09 |
Actual start date | 2020-01-09 |
Estimated end date | 2020-01-31 |
Actual end date | 2020-01-30 |
Shortage status | Resolved |
Updated date | 2020-01-31 |
Company comments | Limited inventory available and on preventative allocation. Other presentation available: 50mg 30's |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-01-31 | French | Compare |
v8 | 2020-01-31 | English | Compare |
v7 | 2020-01-23 | French | Compare |
v6 | 2020-01-23 | English | Compare |
v5 | 2020-01-10 | English | Compare |
v4 | 2020-01-09 | French | Compare |
v3 | 2020-01-09 | English | Compare |
v2 | 2020-01-07 | French | Compare |
v1 | 2020-01-07 | English | Compare |
Showing 1 to 9 of 9